Sequella's Grant - XIII Round

Sequella raised a round of funding on April 18, 2011. Investors include National Institutes of Health.

Sequella is a clinical stage antiinfectives company focused on discovering, developing, and commercializing improved treatments for serious infectious diseases. The company leverages its global influe…

Articles about Sequella's Grant - XIII Round: